Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 May;84(Suppl 2):1–3. doi: 10.1054/bjoc.2001.1755

‘Background to clinical guidelines in cancer’: SOR, a programmatic approach to guideline development and aftercare

G Browman 1
PMCID: PMC2408842  PMID: 11355959

Full Text

The Full Text of this article is available as a PDF (35.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Browman G. P. Evidence-based paradigms and opinions in clinical management and cancer research. Semin Oncol. 1999 Jun;26(3 Suppl 8):9–13. [PubMed] [Google Scholar]
  2. Browman G. P., Levine M. N., Graham I., Whelan T., Sawka C., Pritchard K. I., Jadad A., Newman T. E. The clinical practice guideline: an evolving health care technology. Cancer Prev Control. 1997;1(1):7–8. [PubMed] [Google Scholar]
  3. Browman G. P., Levine M. N., Mohide E. A., Hayward R. S., Pritchard K. I., Gafni A., Laupacis A. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995 Feb;13(2):502–512. doi: 10.1200/JCO.1995.13.2.502. [DOI] [PubMed] [Google Scholar]
  4. Browman G. P., Newman T. E., Mohide E. A., Graham I. D., Levine M. N., Pritchard K. I., Evans W. K., Maroun J. A., Hodson D. I., Carey M. S. Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback. J Clin Oncol. 1998 Mar;16(3):1226–1231. doi: 10.1200/JCO.1998.16.3.1226. [DOI] [PubMed] [Google Scholar]
  5. Cabana M. D., Rand C. S., Powe N. R., Wu A. W., Wilson M. H., Abboud P. A., Rubin H. R. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999 Oct 20;282(15):1458–1465. doi: 10.1001/jama.282.15.1458. [DOI] [PubMed] [Google Scholar]
  6. Cook D. J., Guyatt G. H., Laupacis A., Sackett D. L., Goldberg R. J. Clinical recommendations using levels of evidence for antithrombotic agents. Chest. 1995 Oct;108(4 Suppl):227S–230S. doi: 10.1378/chest.108.4_supplement.227s. [DOI] [PubMed] [Google Scholar]
  7. Evans W. K., Newman T., Graham I., Rusthoven J. J., Logan D., Shepherd F. A., Chamberlain D. Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group. J Clin Oncol. 1997 Sep;15(9):3049–3059. doi: 10.1200/JCO.1997.15.9.3049. [DOI] [PubMed] [Google Scholar]
  8. Fervers B., Bonichon F., Demard F., Heron J. F., Mathoulin S., Philip T., Renaud-Salis J. L., Toma C., Bey P. Méthodologie de développement des standards, options et recommandations diagnostiques et thérapeutiques en cancérologie. Bull Cancer. 1995 Oct;82(10):761–767. [PubMed] [Google Scholar]
  9. Mulrow C. D. Rationale for systematic reviews. BMJ. 1994 Sep 3;309(6954):597–599. doi: 10.1136/bmj.309.6954.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ray-Coquard I., Philip T., Lehmann M., Fervers B., Farsi F., Chauvin F. Impact of a clinical guidelines program for breast and colon cancer in a French cancer center. JAMA. 1997 Nov 19;278(19):1591–1595. [PubMed] [Google Scholar]
  11. Sackett D. L., Rosenberg W. M., Gray J. A., Haynes R. B., Richardson W. S. Evidence based medicine: what it is and what it isn't. BMJ. 1996 Jan 13;312(7023):71–72. doi: 10.1136/bmj.312.7023.71. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES